Regulatory leadership DREHM Pharma is Austria’s largest consultant and service provider for Regulatory Affairs, Pharmacovigilance, Audits, and Quality Management, presenting a strong cross-sell opportunity to expand services into organizations seeking end-to-end compliance and lifecycle management.

Multi-disciplinary expertise With a diverse team of pharmacists, medical professionals, veterinarians, nutritionists, chemists, and molecular biologists, there is potential to pitch integrated, topic-specific engagements and project-based teams to cover broad regulatory and scientific needs for clients.

Transformation momentum The shift to a self-organized, employee-satisfaction driven model since 2021 highlights a culture of agility and high engagement, which can be a talking point when proposing scalable, collaborative delivery models for larger pharma clients.

Recent accomplishments Recent successes include PMCA Gala 2024 nomination for a project with Fresenius Kabi and four successful Austria Switch applications in 2024, signaling capability to win and deliver on complex regulatory and market access initiatives.

Growth and spend signals Reported revenue between one and ten million USD and a growing team suggest capacity for المزيد of project work, indicating opportunities for mid-market pharma companies seeking regulatory consulting, pharmacovigilance, and quality management support at scale.